EMA Committee grants positive opinion for Veklury use to treat COVID 19 in people with Hepatic impairment Ruchika Sharma22 Sept 2023 3:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
USFDA nod to Gilead Sciences Veklury to treat COVID19 in people with mild to severe hepatic impairment with no dose adjustment Ruchika Sharma27 Aug 2023 2:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug...
Gilead Sciences gets USFDA nod for Veklury for COVID treatment in patients with severe renal impairment, including those on dialysis Ruchika Sharma15 July 2023 3:30 PM ISTThe updated prescribing information for Veklury does not require dose adjustments for renally-impaired patients and removes the requirement for eGFR...
EMA panel grants positive opinion for Remdesivir use in COVID patients with severe renal impairment, including those on dialysis: Gilead Sciences Ruchika Sharma28 May 2023 12:00 PM ISTFoster City: Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
Gilead Sciences Remdesivir gets USFDA nod for young children Ruchika Sharma26 April 2022 3:06 PM ISTUnder the expanded indication, a three-day Remdesivir treatment regimen is recommended to help prevent hospitalization in non-hospitalized COVID-19...
Gilead Sciences Remdesivir gets USFDA nod to treat non-hospitalized COVID patients Ruchika Sharma25 Jan 2022 1:48 PM ISTFoster City: Gilead Sciences, Inc. has recently announced that the U.S. Food and Drug Administration (USFDA) has granted expedited approval of a...
Gilead Sciences to amplify availability of Remdesivir in India Ruchika Sharma28 April 2021 12:16 PM ISTFoster City: Gilead Sciences has recently announced that in response to the rapid increase in COVID-19 cases in India, the company is providing its...
Gilead remdesivir not associated with kidney problems in COVID-19 patients: European panel Ruchika Sharma14 Feb 2021 10:00 AM ISTNew Delhi: Europe's drugs regulator said on Friday its safety panel found no evidence that Gilead's remdesivir caused kidney problems in some COVID-19...
Gilead Sciences Covid drug Remdesivir Becomes First Treatment to Win USFDA Nod Ruchika Sharma24 Oct 2020 4:48 PM ISTNew Delhi: Gilead Sciences has recently been granted approval by the U.S. Food and Drug Administration(USFDA) for antiviral drug Veklury (remdesivir)...
FDA approves remdesivir for treating hospitalized COVID-19 patients Dr. Kamal Kant Kohli23 Oct 2020 4:50 AM ISTThe US Food and drug administration has approved the antiviral drug remdesivir for treating hospitalized COVID-19 patients—adults and children ages 12...
